Published in Lab Invest on July 01, 2000
Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One (2012) 2.01
Inflammation in the pathogenesis of lyme neuroborreliosis. Am J Pathol (2015) 1.49
OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients. J Clin Microbiol (2002) 1.41
Borrelia burgdorferi transcriptome in the central nervous system of non-human primates. Proc Natl Acad Sci U S A (2003) 1.26
The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med (2008) 1.20
Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol (2008) 1.19
Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun (2005) 1.17
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun (2008) 1.10
Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation (2009) 1.06
Lyme disease. Clin Lab Med (2010) 1.01
Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi. Infect Immun (2003) 0.99
Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog (2009) 0.94
Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun (2005) 0.91
A disconnect between the neurospirochetoses in humans and rodent models of disease. PLoS Pathog (2013) 0.91
Chronic Lyme Disease and Co-infections: Differential Diagnosis. Open Neurol J (2012) 0.88
Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun (2006) 0.88
The mammalian host response to borrelia infection. Wien Klin Wochenschr (2006) 0.87
Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells. Infect Immun (2007) 0.86
Interleukin 10 protects the brain microcirculation from spirochetal injury. J Neuropathol Exp Neurol (2008) 0.83
Fibromyalgia: When Distress Becomes (Un)sympathetic Pain. Pain Res Treat (2011) 0.82
Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection. Lab Invest (2013) 0.82
The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi. ASN Neuro (2013) 0.80
Issues in the diagnosis and treatment of lyme disease. Open Neurol J (2012) 0.78
Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system. J Neuroinflammation (2015) 0.77
Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research. J Vis Exp (2013) 0.77
Targeting CXCL13 During Neuroinflammation. Adv Neuroimmune Biol (2015) 0.76
Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015). J Vet Intern Med (2016) 0.75
Effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in glial and neuronal cells of the central nervous system. J Neuroinflammation (2017) 0.75
Regulated Production of CXCL13 within the Central Nervous System. J Clin Cell Immunol (2016) 0.75
The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55
Measurement of shoulder related disability: results of a validation study. Ann Rheum Dis (1994) 2.70
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology (2009) 2.36
[A method for the quantitative determination of human sebum secretion]. Arch Klin Exp Dermatol (1970) 2.34
Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry (2012) 2.20
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Am J Transplant (2014) 1.73
Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system. Ann Neurol (1995) 1.70
Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol (1999) 1.67
The evolution and loss of oil-offering flowers: new insights from dated phylogenies for angiosperms and bees. Philos Trans R Soc Lond B Biol Sci (2010) 1.54
The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone (1993) 1.53
A case of group B streptococcal pyomyositis. Rev Infect Dis (1990) 1.46
[Do magnetic fields cause cancer?]. Med Klin (Munich) (1992) 1.40
[Photometrical determination of enzyme activities in living epidermal cells]. Arch Klin Exp Dermatol (1971) 1.39
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31
Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Br J Dermatol (1980) 1.29
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant (2005) 1.27
[In vitro-penetration of radiolabelled hydrocortisone in various vehicles in human skin (author's transl)]. Arch Dermatol Forsch (1973) 1.26
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine. Vaccine (2002) 1.25
Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J Invest Dermatol (1975) 1.25
[Penetration of radioactive hydrocortisone in human skin from various ointment bases. II. In vivo-experiments (author's transl)]. Arch Dermatol Forsch (1975) 1.24
[Control of horny layer stripping by skin resistance measurements]. Arch Dermatol Forsch (1972) 1.21
Neurological findings of Lyme disease. Yale J Biol Med (1985) 1.21
Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. J Am Acad Dermatol (1984) 1.19
Nasal glioma presenting as capillary haemangioma. Eur J Pediatr (2001) 1.18
[Penetration of various labelled steroids into human skin]. Arzneimittelforschung (1973) 1.17
Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology (1995) 1.16
Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease. AIDS Res Hum Retroviruses (1991) 1.16
In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol (1983) 1.16
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
[Biochemical studies on the chemotherapy of psoriasis]. Arch Klin Exp Dermatol (1970) 1.10
An excess of widespread pain among South Asians: are low levels of vitamin D implicated? Ann Rheum Dis (2005) 1.10
8-Methoxypsoralen: its isolation and gas chromatographic determination from aqueous solutions and serum. Biochem Med (1977) 1.09
Nonthermal melting of a charge density wave in TiSe2. Phys Rev Lett (2011) 1.08
False negative findings in intraoperative SEP monitoring: analysis of 658 consecutive neurosurgical cases and review of published reports. J Neurol Neurosurg Psychiatry (2004) 1.07
Evaluation of candidate DNA barcoding loci for economically important timber species of the mahogany family (Meliaceae). Mol Ecol Resour (2011) 1.07
Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm (1999) 1.06
Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol (2004) 1.05
Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro. Br J Dermatol (1979) 1.02
Some observations on 112 pectoralis major myocutaneous flaps. Am J Surg (1984) 1.02
Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology (1997) 1.01
Penetration, permeation, and resorption of 8-methoxypsoralen. Comperative in vitro and in vivo studies after topical application of four standard preparations. Arch Dermatol Res (1976) 1.00
[Medical and social findings in coronary heart diseases]. Munch Med Wochenschr (1969) 0.99
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens. Vaccine (2001) 0.99
Eosinophilic granuloma of the gastro-intestinal tract. Case report and suggested classification. Br J Surg (1970) 0.97
PUVA appraisal. Br J Dermatol (1978) 0.97
Functionally relevant membrane proteins of human and guinea-pig T lymphocytes. Mol Immunol (1986) 0.97
Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res (1993) 0.97
[Significance of triglyceride splitting by C. acnes in acne vulgaris (author's transl)]. Arch Dermatol Forsch (1973) 0.97
8-Methoxypsoralen (8-MOP) in human skin: penetration kinetics. J Invest Dermatol (1978) 0.96
Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units. J Virol (1976) 0.95
8-Methoxypsoralen-gas chromatographic determination and serum kinetics. Arch Dermatol Res (1978) 0.95
[Method for in vivo determination of human epidermal enzymes]. Arch Dermatol Forsch (1972) 0.95
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy (2010) 0.95
Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody. Clin Diagn Lab Immunol (2001) 0.94
The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet Rec (1993) 0.93
On the ionization constant of 5-ribosyluracil. Biochemistry (1965) 0.93
[Comparative enzyme measurements in normal and psoriatic skin]. Arch Dermatol Forsch (1973) 0.92
Facial paralysis in Lyme disease. Laryngoscope (1985) 0.92
[Penetration of topical steroids through heman skin: dependence upon ointment bases]. Arch Dermatol Forsch (1974) 0.92
Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro. Acta Derm Venereol (1974) 0.91
Neuro-ophthalmologic manifestations of Lyme disease. Ophthalmology (1990) 0.91
Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol (1992) 0.91
Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol (1999) 0.91
Disseminated islands of gastric mucosa in jejunum and ileum detected by technetium-99m-pertechnetate scintigraphy. J Nucl Med (1997) 0.90
Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.90
Short-contact therapy. Arch Dermatol (1985) 0.90
Antigen-specific proliferation of CSF lymphocytes in Lyme disease. Neurology (1985) 0.90
Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol (2001) 0.90
Nerve stimulation test in murine experimental autoimmune myasthenia gravis. Ann Neurol (1982) 0.90
The stripping technique: in vitro absorption and penetration of five UV filters on excised fresh human skin. Skin Pharmacol Appl Skin Physiol (2001) 0.89
Fatal herpesvirus infection in patas monkeys and a black and white colobus monkey. J Am Vet Med Assoc (1981) 0.89
Absolute concentrations of an antimycotic agent, econazole, in the human skin after local application. Arzneimittelforschung (1976) 0.89
Treatment of malignant melanoma by intravascular 4-hydroxyanisole. Clin Oncol (1981) 0.89
Hydrocortisone (cortisol) concentration and penetration gradient. Acta Derm Venereol (1977) 0.89
A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Osteoporos Int (2012) 0.88
Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia (2003) 0.88
Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts. J Infect Dis (1999) 0.88
[Penetrations kinetics and distribution of topically applied estrogens (author's transl)]. Arch Dermatol Res (1976) 0.88
The quantitative distribution of percutaneously applied caffeine in the human skin. Arch Dermatol Res (1979) 0.88
Risk of anal furunculosis in German shepherd dogs is associated with the major histocompatibility complex. Tissue Antigens (2007) 0.88
[Penetration of a non-steroidal anti-inflammatory drug into human skin in vitro and in vivo. Tissue concentrations and flow rates of p-butoxyphenylacetohydroxamic acid (author's transl)]. Arzneimittelforschung (1978) 0.87
[Effect of systemically administered prednisolone and methotrexate on lactate dehydrogenase activity of the human epidermis]. Arzneimittelforschung (1973) 0.87
Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol (2001) 0.87
Cytokine inhibition of DNA synthesis: effect on cyclic adenosine monophosphate in lymphocytes. Science (1976) 0.87
The gastrocnemius myocutaneous flap used as a over for the exposed knee prosthesis. J Bone Joint Surg Br (1981) 0.87
[Follicular penetration. An important pathway for topically applied substances]. Hautarzt (2003) 0.86
Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol (1992) 0.86
Evaluation of femoral nerve blockade following inguinal paravascular block of Winnie: are there still lessons to be learnt? Anaesthesia (2005) 0.85
Comparison of transepidermal water loss and spectroscopic absorbance to quantify changes of the stratum corneum after tape stripping. Skin Pharmacol Physiol (2005) 0.85
Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res Vet Sci (1993) 0.85
Experimental low-level direct current therapy in liver metastases: influence of polarity and current dose. Bioelectromagnetics (2000) 0.85
Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr Probl Dermatol (1978) 0.84
Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol (1997) 0.84
Evaluation of the pseudo-absorption method to quantify human stratum corneum removed by tape stripping using protein absorption. Skin Pharmacol Appl Skin Physiol (2003) 0.84
The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies. Neurology (1986) 0.84
Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts. Vaccine (1999) 0.84
Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture, and a bioassay. J Clin Microbiol (1998) 0.84